![](/img/cover-not-exists.png)
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine
Svensson, Tobias, Chowdhury, Onima, Garelius, Hege, Lorenz, Fryderyk, Saft, Leonie, Jacobsen, Sten-Eirik, Hellström-Lindberg, Eva, Cherif, HonarVolume:
93
Language:
english
Journal:
European Journal of Haematology
DOI:
10.1111/ejh.12383
Date:
November, 2014
File:
PDF, 358 KB
english, 2014